Literature DB >> 25436396

Why it's time for updated U.S. colorectal cancer prevention guidelines in inflammatory bowel disease.

David T Rubin1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25436396     DOI： 10.1016/j.gie.2014.08.030

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  2 in total

Review 1.  Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review.

Authors:  Ruben J Colman; David T Rubin
Journal:  Intest Res       Date:  2016-06-27

2.  Anti-inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis.

Authors:  Fei Ge; Shilin Zhu; Lina Liu; Jing Yan; Yu Ji; Zhiguang Sun
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.